We are live on ! Find out more
HPTX

HYPERION THERAPEUTICS INC COM STK (DE)
HPTX

Delisted

HPTX was delisted on the 7th of May, 2015.

90 hedge funds and large institutions have $413M invested in HYPERION THERAPEUTICS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

625% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 4

79% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 19

38% more funds holding

Funds holding: 6590 (+25)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

6% more capital invested

Capital invested by funds: $390M → $413M (+$22.9M)

Holders
90
Holders Change
+25
Holders Change %
+38.46%
% of All Funds
2.59%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
29
Increased
34
Reduced
19
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$79M +$805K +31,308 +1%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$65.9M -$278K -10,800 -0.4%
NMC
3
NEA Management Company
Maryland
$62.2M -$12.9M -500,000 -17%
HMPV
4
Highland Management Partners VII
Massachusetts
$47.3M -$974K -37,900 -2%
CCM
5
Consonance Capital Management
New York
$33.4M +$6.5M +252,956 +25%
GPP
6
Great Point Partners
Connecticut
$17.2M +$4.22M +164,233 +33%
Wells Fargo
7
Wells Fargo
California
$10.3M +$78.8K +3,065 +0.8%
BFA
8
BlackRock Fund Advisors
California
$8.75M +$2.57M +99,784 +42%
Vanguard Group
9
Vanguard Group
Pennsylvania
$8.44M +$193K +7,515 +2%
Franklin Resources
10
Franklin Resources
California
$7.21M -$864K -33,600 -11%
Lord, Abbett & Co
11
Lord, Abbett & Co
New Jersey
$5.03M +$919K +35,732 +23%
State Street
12
State Street
Massachusetts
$4.42M +$1.15M +44,778 +36%
BIT
13
BlackRock Institutional Trust
California
$4.07M -$220K -8,570 -5%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$3.38M +$741K +28,841 +29%
Allianz Asset Management
15
Allianz Asset Management
Germany
$3.09M -$314K -12,225 -9%
Northern Trust
16
Northern Trust
Illinois
$2.99M -$429K -16,707 -13%
RHJA
17
Rice Hall James & Associates
California
$2.95M -$10.5K -409 -0.4%
Invesco
18
Invesco
Georgia
$2.4M +$2.16M +84,122 +1,062%
TC
19
TFS Capital
Pennsylvania
$2.23M +$1.01M +39,445 +86%
MSA
20
Mason Street Advisors
Wisconsin
$2.21M
EAM
21
Eventide Asset Management
Massachusetts
$1.99M +$118K +4,600 +6%
Millennium Management
22
Millennium Management
New York
$1.97M +$1.21M +47,108 +167%
RPAM
23
Rhenman & Partners Asset Management
Sweden
$1.84M -$85.7K -3,333 -5%
Morgan Stanley
24
Morgan Stanley
New York
$1.79M +$1.51M +58,658 +584%
PAI
25
Palo Alto Investors
California
$1.64M

HPTX Hedge Fund Activity: Q2 2014 in Review

90 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) for Q2 2014, worth a combined $413M — up 5.9% from $390M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new HPTX positions and 4 closed out — a net gain of 25 holders — while 34 added to existing stakes and 19 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $6.5M. The largest seller was NEA Management Company, cutting an estimated $12.9M.

  • 90 institutional investors held HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) as of Q2 2014, up from 65 in Q1 2014.
  • Funds reported $413M of HYPERION THERAPEUTICS INC COM STK (DE) stock for Q2 2014, up 5.9% quarter-over-quarter.
  • 29 funds opened new HYPERION THERAPEUTICS INC COM STK (DE) positions in Q2 2014 and 4 closed out, a net change of +25 holders.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) buyer in Q2 2014 was Consonance Capital Management, an estimated $6.5M added.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) seller in Q2 2014 was NEA Management Company, an estimated $12.9M sold.

Based on aggregated 13F filings for Q2 2014.